Forbion invests USD 2.3M in seed financing of CoviCept Therapeutics, Inc.
01/19/21, 8:04 AM
Location
west palm beachMoney raised
$2 million
Industry
venture capital
life science
biotechnology
Round Type
seed
Forbion, a leading European life sciences venture capital firm, today announces a $2.3m seed investment in newly formed CoviCept Therapeutics, Inc. (“CoviCept”), a California-based company that is developing a small molecule that inhibits the replication of SARS-CoV-2 (COVID-19) and other RNA viruses.
Company Info
Location
west palm beach, florida, united states
Additional Info
With approximately €3 billion in assets under management, Forbion provides capital and expertise to life sciences companies, enabling the development of new therapeutics that can impact the future of medicine. Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. Forbion Forbion is a dedicated life sciences venture capital firm with offices in The Netherlands, Germany, and Singapore.